Article | January 11, 2022

Preclinical And Nonclinical Studies—What Is The Difference, And Where In Your Program Should They Fall?

Source: Premier Consulting

By Camille Delouche, MSc, Commercial Operations Associate

Opportunities In Preclinical Development

Have you ever wondered about the difference between preclinical and nonclinical studies? While those in scientific fields like pharmaceutical development are accustomed to words with specific agreed-upon definitions to facilitate communication and minimize misunderstandings, these two terms seem to have slipped through the cracks. Their similar meanings often make it difficult to determine which word is appropriate in a given context and which studies fit their definitions across the development landscape.

So when should each term be used, and what are the appropriate timelines for preclinical and nonclinical studies within a drug development program?

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online